These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia]. Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771 [TBL] [Abstract][Full Text] [Related]
5. Amiodarone: a unique antiarrhythmic agent. Sloskey GE Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912 [TBL] [Abstract][Full Text] [Related]
6. Amiodarone: pharmacological profile, animal-model experimental data and clinical use. How important is the vasodilating effect? Hatzitolios A; Ntaios G; Savopoulos C Int Angiol; 2009 Oct; 28(5):353-62. PubMed ID: 19935588 [TBL] [Abstract][Full Text] [Related]
7. Amiodarone. Smith WC; Reddy CP J La State Med Soc; 1989 May; 141(5):35-8. PubMed ID: 2659709 [TBL] [Abstract][Full Text] [Related]
9. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment. Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion. Somani P; Simon VA; McManus K Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764 [TBL] [Abstract][Full Text] [Related]
11. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome. Riera AR; Uchida AH; Ferreira C; Ferreira Filho C; Schapachnik E; Dubner S; Zhang L; Moffa PJ Cardiol J; 2008; 15(3):209-19. PubMed ID: 18651412 [TBL] [Abstract][Full Text] [Related]
12. Benzofuran derivatives and the thyroid. Han TS; Williams GR; Vanderpump MP Clin Endocrinol (Oxf); 2009 Jan; 70(1):2-13. PubMed ID: 18727707 [TBL] [Abstract][Full Text] [Related]
13. Amiodarone in the prevention and treatment of arrhythmia. Auer J; Berent R; Eber B Curr Opin Investig Drugs; 2002 Jul; 3(7):1037-44. PubMed ID: 12186264 [TBL] [Abstract][Full Text] [Related]
15. Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents. Perry RS; Illsley SS Am J Hosp Pharm; 1986 Apr; 43(4):957-74. PubMed ID: 2871752 [TBL] [Abstract][Full Text] [Related]
16. [Amiodarone administered orally or intravenously - the same or different drug?]. Kosior DA; Krzykwa A; PostuĊa M Pol Merkur Lekarski; 2013 Apr; 34(202):183-7. PubMed ID: 23745321 [TBL] [Abstract][Full Text] [Related]
17. [Antiarrhythmic agents in the prevention of sudden cardiac death]. Halawa B Pol Merkur Lekarski; 1999 Mar; 6(33):117-20. PubMed ID: 10365592 [TBL] [Abstract][Full Text] [Related]
18. Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: evidence for an altered response in diabetic patients. Iervasi G; Clerico A; Bonini R; Nannipieri M; Manfredi C; Sabatino L; Biagini A; Donato L Int J Clin Pharmacol Res; 1998; 18(3):109-20. PubMed ID: 9825267 [TBL] [Abstract][Full Text] [Related]
19. Amiodarone: a late comer. Futterman LG; Lemberg L Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203 [TBL] [Abstract][Full Text] [Related]
20. The role of class III antiarrhythmic agents in maintaining sinus rhythm. Brachmann J Europace; 2000 Jul; 1 Suppl C():C10-5. PubMed ID: 11220519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]